Why NETGEAR Shares Are Trading Lower By 18%? Here Are Other Stocks Moving In Thursday's Mid-Day Session

Gainers

  • Evelo Biosciences, Inc. EVLO jumped 147.9% to $0.2479. Evelo Biosciences shares dropped 33% on Wednesday after the company announced top-line data from the fourth cohort of its EDP1815 Phase 2 trial, in which the primary endpoint was not met.
  • ContraFect Corporation CFRX gained 87% to $2.4693. ContraFect said first patient was dosed in the Phase 1b/2 study of exebacase in patients with chronic prosthetic joint infections of the knee.
  • Hillstream BioPharma, Inc. HILS jumped 56% to $1.10.
  • TOP Financial Group Limited TOP rose 53.7% to $10.33.
  • U Power Limited UCAR climbed 33.5% to $5.45 after declining around 27% on Wednesday.
  • Atomera Incorporated ATOM shares gained 23.6% to $6.45 after the company posted results for its first quarter. The company announced the execution of a commercial license agreement with STMicroelectronics (ST) that enables the latter to install Atomera's Mears Silicon Technology into its facilities.
  • OMNIQ Corp. OMQS climbed 20.8% to $5.47.
  • Vapotherm, Inc. VAPO rose 19.4% to $0.5001.
  • Helen of Troy Limited HELE shares gained 19.1% to $97.39 after the company announced better-than-expected Q4 results.
  • Nuburu, Inc. BURU gained 19% to $1.13.
  • Bel Fuse Inc. BELFB rose 18.3% to $36.25 following better-than-expected quarterly results.
  • Immuron Limited IMRN gained 16.4% to $2.23.
  • CXApp Inc. CXAI climbed 16% to $10.74.
  • Mainz Biomed N.V. MYNZ gained 15.6% to $3.92.
  • Accuray Incorporated ARAY jumped 15% to $3.1050 after the company reported better-than-expected Q3 EPS and sales results.
  • LianBio LIAN rose 14.7% to $2.26. LianBio announced topline results from the Phase 3 EXPLORER-CN trial investigating mavacamten for Chinese patients with symptomatic obstructive hypertrophic cardiomyopathy (oHCM).
  • Meta Platforms, Inc. META climbed 14.3% to $239.64 as the company reported better-than-expected Q1 results and also announced an increase in active users.
  • Immix Biopharma, Inc. IMMX gained 14.1% to $2.13 after Nexcella, an Immix Biopharma subsidiary, disclosed positive 58-patient NXC-201 clinical data.
  • GRI Bio, Inc. GRI gained 14.1% to $6.79.
  • Goosehead Insurance, Inc GSHD jumped 13.8% to $61.15 following upbeat quarterly results.
  • Overstock.com, Inc. OSTK rose 13.7% to $20.54 following strong quarterly results.
  • Ardagh Metal Packaging S.A. AMBP gained 13.5% to $3.93 following Q1 results.
  • Materialise NV MTLS gained 13% to $8.80 as the company posted upbeat Q1 results and named Koen Berges as CFO.
  • Cimpress plc CMPR jumped 12.4% to $48.72 following strong quarterly sales.
  • Hasbro, Inc. HAS gained 10.8% to $57.00 after the company reported better-than-expected Q1 sales results and reiterated FY23 adjusted EPS guidance above the estimate.
  • Mangoceuticals, Inc MGRX surged 10.7% to $1.3418 after dropping around 33% on Wednesday. Mangoceuticals recently commenced online sales campaign with DojoLabs Group.
  • Getaround, Inc. GETR climbed 9.9% to $0.4999. Getaround received continued listing standard notice from NYSE related to delayed filing of Form 10-K.
  • Kaiser Aluminum Corporation KALU gained 9.7% to $63.82 following Q1 results.
  • OpGen, Inc. OPGN gained 6% to $0.88 after the company said its German subsidiary Curetis GmbH has met the remaining key milestones under the initial research and development collaboration agreement with FIND.

Losers

  • Baudax Bio, Inc. BXRX fell 52.5% to $0.8406 after the company reported the pricing of $4 million public offering.
  • Impinj, Inc. PI dropped 35.2% to $87.71 after the company reported mixed Q1 results and issued weak guidance.
  • 4D Molecular Therapeutics, Inc. FDMT shares fell 31.1% to $14.18. 4DMT presented interim data from intravitreal 4D-150 Phase 1/2 PRISM clinical trial in patients with wet AMD at ARVO 2023.
  • Aspen Technology, Inc. AZPN fell 25% to $173.76 after the company posted downbeat Q3 results and issued weak FY23 forecast.
  • Mobileye Global Inc. MBLY dropped 22% to $33.58 after the company lowered FY23 revenue guidance below estimates.
  • Crown ElectroKinetics Corp. CRKN fell 20.6% to $0.1206. Crown Electrokinetics recently issued a letter to shareholders.
  • Satixfy Communications Ltd. SATX dropped 19.8% to $0.8101.
  • PROCEPT BioRobotics Corporation PRCT fell 19.2% to $28.89 following wider-than-expected Q1 loss.
  • Crocs, Inc. CROX fell 18.5% to $120.35 after the company reported Q1 earnings results and after the company issued Q2 guidance.
  • ETAO International Co., Ltd. ETAO shares dropped 18.3% to $0.96 after gaining around 57% on Wednesday.
  • NETGEAR, Inc. NTGR dipped 18.1% to $13.77 following weak quarterly results.
  • Ideanomics, Inc. IDEX fell 17.2% to $0.0227 after dropping around 22% on Wednesday.
  • Kuke Music Holding Limited KUKE dropped 16.9% to $0.60.
  • Wolfspeed, Inc. WOLF fell 16.2% to $48.11 after the company issued weak Q4 guidance.
  • Avinger, Inc. AVGR fell 15.5% to $0.54.
  • MaxLinear, Inc. MXL dipped 15.5% to $24.78 after the company issued weak Q2 guidance.
  • IN8bio, Inc. INAB fell 13.3% to $1.6902. IN8bio announced oral presentation of new INB-200 Phase 1 data in glioblastoma to be presented at 2023 ASCO Annual Meeting.
  • H&E Equipment Services, Inc. HEES declined 12% to $36.36 following Q1 results.
  • Align Technology, Inc. ALGN fell 11.7% to $312.85 after the company reported Q1 financial results and issued guidance.
  • Opera Limited OPRA dropped 11.6% to $10.04 following Q1 results.
  • Sonic Automotive, Inc. SAH gained 11.3% to $46.28 following weak quarterly results.
  • American Rebel Holdings, Inc. AREB shares fell 11% to $0.1371 after gaining around 14% on Wednesday.
  • National Energy Services Reunited Corp. NESR dipped 11% to $2.94 after the company announced it was not able to file its Annual Report on Form 20-F for its fiscal year ended December 31, 2021 with the SEC.
  • Clearmind Medicine Inc. CMND fell 10.5% to $0.62. CONMED said it sees FY23 EPS of $3.30 to $3.50 and revenue of $1.205 billion to $1.250 billion.
  • Morningstar, Inc. MORN dropped 9.3% to $172.95 following Q1 results.
  • AbbVie Inc. ABBV dropped 8.5% to $147.95 after the company reported Q1 financial results and issued FY23 guidance.
  • Mobiquity Technologies, Inc. MOBQ fell 8.4% to $0.1718 after jumping 22% on Wednesday. Mobility Technologies recently announced its AI-powered ad targeting technology.
  • STMicroelectronics N.V. STM shares dropped 8.4% to $42.37 after reporting Q1 results.

Now Read This: Top 5 Health Care Stocks That Could Sink Your Portfolio This Quarter

Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Posted In:
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!